Cancer Research | Metastasis Biology | Cellular Metabolism
Fendt Lab
Loading...
www.sciencedirect.com/science/arti...
@fendtlab.bsky.social postdoc Sebastian Igelmann shares his highlights and experiences from the EACR Tumor Ecosystem conference!
After a huge researcher backlash, the European Research Council has reversed a policy it introduced to help deal with a deluge of applications to its coveted awards.
go.nature.com/428LA6d
Hopefully the beginning of something bigger to ensure that European science prospers today and in the future!
After collective feedback from the research community, the ERC decided to keep the existing resubmission rules for 2027. A reminder that speaking together matters - and that continued advocacy for strong research and funding in Europe is essential.
Grateful to everyone who contributed. #ERC 🇪🇺
In <3 days, our open letter gathered 1,000+ signatures from 36 countries and 200+ institutions reflecting broad concern about restricting ERC applications & strong support for the proposed alternatives + the ERC mission to fund innovative research now and in the future. 🇪🇺 #ERC
We celebrated the "in principle accepted" :o) Stay tuned.
Great short talk and discussion by Dr Sebastian Igelmann at the @helloeacr.bsky.social Tumor Ecosystem Conference and many thanks to EACR-WCR @worldwidecancer.bsky.social who sponsored the travel grant Sebastian received!
What should Europe do when demand for #ERC funding keeps rising?
Restrict access or invest in excellence?
Please read our open letter calling for reconsideration of the ERC 2027 resubmission restrictions & for constructive alternatives that preserve openness
Consider to share & sign - see below 🧪
I argued that when a grant rejection can hinge on something small, and you then have to wait years to resubmit, the cost becomes so high that instead of suggesting “high-risk high-gain” plans scientists will prepare more cautious, less ambitious proposals (2/3)
The Lancet Commission on women, power, and cancer recommends that women have equitable access to cancer research resources, leadership, and funding op…
What should Europe do when demand for its most successful frontier research programme keeps rising?
Restrict access, or invest in the excellence it has created?
A new open letter, spearheaded by Sara...
EACR Travel Grant winners share their reflections on attending the most recent edition of our cutting-edge The Tumour Ecosystem conference, including what they learned and how the experience supported their research journey.
Read the full article here: magazine.eacr.org/eacr-travel-...
New piece on the decision of #ERC to reverse their stricter rules after the community came together to voice our opinions - a great example of the power of collective action!
Very happy to have been part of this - and to see how we can now build on this momentum 🙌
www.nature.com/articles/d41... 🧪
In <3 days, our open letter gathered 1,000+ signatures from 36 countries and 200+ institutions reflecting broad concern about restricting ERC applications & strong support for the proposed alternatives + the ERC mission to fund innovative research now and in the future. 🇪🇺 #ERC
What should Europe do when demand for #ERC funding keeps rising?
Restrict access or invest in excellence?
Please read our open letter calling for reconsideration of the ERC 2027 resubmission restrictions & for constructive alternatives that preserve openness
Consider to share & sign - see below 🧪
Johanna Joyce
The tough new policy was introduced to curb submissions, but drew criticism from researchers.
What should Europe do when demand for its most successful frontier research programme keeps rising?
Restrict access, or invest in the excellence it has created?
A new open letter, spearheaded by Sara...
What should Europe do when demand for #ERC funding keeps rising?
Restrict access or invest in excellence?
Please read our open letter calling for reconsideration of the ERC 2027 resubmission restrictions & for constructive alternatives that preserve openness
Consider to share & sign - see below 🧪
What should Europe do when demand for its most successful frontier research programme keeps rising?
Restrict access, or invest in the excellence it has created?
A new open letter, spearheaded by Sara...
